Non-Invasive Prenatal Testing Market Size, Share, Trends, Growth, Regional Outlook and Forecast 2025 - Credence ResearchBusiness EnterprisesUpdated on Oct 2, 2018 View more like this | Visit NEW YORK, NY | Contact Acute Market Reports |
The report includes forecast and analysis for the Global Non-Invasive Prenatal Testing market on a global and regional level. The research gives important data of 2015, 2016 and 2017 along with a projection from 2018 to 2026 based on revenue. The study covers drivers and limitations of the Global Non-Invasive Prenatal Testing market along with the impact they have on the trade over the forecast period. Additionally, the report covers the study of possibilities available in the Global Non-Invasive Prenatal Testing market on a global level.
Browse Report: https://www.credenceresearch.com/report/non-invasive-prenatal-testing-market
Market Insights
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure.
Non-invasive prenatal testing is defined as a highly sensitive screening process that assists in detecting chromosomal abnormalities in the fetus during pregnancy. Some of such chromosomal abnormal abilities that can be detected through NIPT are Down syndrome, Patau syndrome, Edwards’ syndrome and Turner syndrome.
Among the available NIPT tests, the MaternitT21 test is the largest segment and it is anticipated that its dominance will continue through 2022. It was the first test to receive approval for detection of Trisomy 21 in 2011. Other chromosomal abnormalities that could be detected with MaternitT21 are Wolf-Hirschhorn syndrome, DiGeorge syndrome, Langer-Giedion syndrome, 1q36 deletion syndrome and Jaconsen syndrome. MaterniT21 used cfDNA and parallel sequencing technology and delivers results in a 5 day period.
Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/57840
The report aims to present a study of Global Global Non-Invasive Prenatal Testing Market along with accurate segmentation of market by type, solution, application and five major geographical regions. Global Global Non-Invasive Prenatal Testing market is supposed to witness a high increase during the forecast years due to expanding risk of data theft and firm government regulation.
The report also tracks the major market functions including product launches, technological advancements, mergers & benefits, and the innovative market tactics opted by key market players. Along with strategically examining the key micro markets, the paper also focuses on industry-specific drivers, restraints, possibilities and challenges in the Global Non-Invasive Prenatal Testing market.
The objectives of this report are as follows:
-To present overview of the global Global Non-Invasive Prenatal Testing market
-To examine and forecast the global Global Non-Invasive Prenatal Testing market on the basis of types, explications, and applications
To present market size and forecast till 2026 for overall Global Non-Invasive Prenatal Testing market with respect to five major regions, namely; North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and South America (SAM), which are later sub-segmented over respective major countries
-To evaluate market dynamics effecting the market during the projection period i.e., drivers, barriers, opportunities, and coming trend
-To provide exhaustive PEST analysis for all five regions
-To profiles key Global Non-Invasive Prenatal Testing players influencing the industry along with their SWOT analysis and market policies
Leading Players:
The major players engaged in the global noninvasive prenatal testing market are LifeCodexx AG, Illumina, Inc., Sequenom, Inc. LABCORP, Natera, Inc. and others.
Study methodology
The research methodology for Credence Research’s Global Non-Invasive Prenatal Testing market report utilizes a key of top-down and bottom-up research arrangements. Our initial focus on continuous market tracking, accurate fact-checking, data-triangulation, and multiple layers of quality control assures high-quality data that can be leveraged for actionable study insights.
Business segmentation
This report examines the Global Non-Invasive Prenatal Testing market by the following segments:
Geographic coverage and Report
This market research report covers the following geographic regions in great detail:
Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/57840
Company Profiles
6.1 Ariosa Diagnostics, Inc.
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Berry Genomics Co., Ltd.
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 BGI Diagnostics
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Illumina, Inc.
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Positions/Portfolio
6.4.4 News Coverage
6.5 Laboratory Corporation of America Holdings (LabCorp)
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Positions/Portfolio
6.5.4 News Coverage
6.6 LifeCodexx AG
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Positions/Portfolio
6.6.4 News Coverage
6.7 Natera, Inc.
6.7.1 Business Description
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Web: https://www.credenceresearch.com
LinkedIn @ https://us.linkedin.com/company/credenceresearch
Browse Report: https://www.credenceresearch.com/report/non-invasive-prenatal-testing-market
Market Insights
The global non-invasive prenatal tests (NIPT) market is experiencing a double-digit growth facilitated by market drivers such as rise in average maternity age, growing incidence of chromosomal abnormalities that demand early and non-invasive detection. Other major factor that aids to the growth of this market is rise in healthcare expenditure.
Non-invasive prenatal testing is defined as a highly sensitive screening process that assists in detecting chromosomal abnormalities in the fetus during pregnancy. Some of such chromosomal abnormal abilities that can be detected through NIPT are Down syndrome, Patau syndrome, Edwards’ syndrome and Turner syndrome.
Among the available NIPT tests, the MaternitT21 test is the largest segment and it is anticipated that its dominance will continue through 2022. It was the first test to receive approval for detection of Trisomy 21 in 2011. Other chromosomal abnormalities that could be detected with MaternitT21 are Wolf-Hirschhorn syndrome, DiGeorge syndrome, Langer-Giedion syndrome, 1q36 deletion syndrome and Jaconsen syndrome. MaterniT21 used cfDNA and parallel sequencing technology and delivers results in a 5 day period.
Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/57840
The report aims to present a study of Global Global Non-Invasive Prenatal Testing Market along with accurate segmentation of market by type, solution, application and five major geographical regions. Global Global Non-Invasive Prenatal Testing market is supposed to witness a high increase during the forecast years due to expanding risk of data theft and firm government regulation.
The report also tracks the major market functions including product launches, technological advancements, mergers & benefits, and the innovative market tactics opted by key market players. Along with strategically examining the key micro markets, the paper also focuses on industry-specific drivers, restraints, possibilities and challenges in the Global Non-Invasive Prenatal Testing market.
The objectives of this report are as follows:
-To present overview of the global Global Non-Invasive Prenatal Testing market
-To examine and forecast the global Global Non-Invasive Prenatal Testing market on the basis of types, explications, and applications
To present market size and forecast till 2026 for overall Global Non-Invasive Prenatal Testing market with respect to five major regions, namely; North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and South America (SAM), which are later sub-segmented over respective major countries
-To evaluate market dynamics effecting the market during the projection period i.e., drivers, barriers, opportunities, and coming trend
-To provide exhaustive PEST analysis for all five regions
-To profiles key Global Non-Invasive Prenatal Testing players influencing the industry along with their SWOT analysis and market policies
Leading Players:
The major players engaged in the global noninvasive prenatal testing market are LifeCodexx AG, Illumina, Inc., Sequenom, Inc. LABCORP, Natera, Inc. and others.
Study methodology
The research methodology for Credence Research’s Global Non-Invasive Prenatal Testing market report utilizes a key of top-down and bottom-up research arrangements. Our initial focus on continuous market tracking, accurate fact-checking, data-triangulation, and multiple layers of quality control assures high-quality data that can be leveraged for actionable study insights.
Business segmentation
This report examines the Global Non-Invasive Prenatal Testing market by the following segments:
- Global Non-Invasive Prenatal Testing Market, by Application
- Global Non-Invasive Prenatal Testing Market, By Technology
- Global Non-Invasive Prenatal Testing Market, By Portability
- Global Non-Invasive Prenatal Testing Market, By Type of Systems
- Global Non-Invasive Prenatal Testing Market, By End Users
- Global Non-Invasive Prenatal Testing Market, By Price Segments
Geographic coverage and Report
This market research report covers the following geographic regions in great detail:
- ASIA-PACIFIC
- NORTH AMERICA
- EUROPE
- MIDDLE EAST & AFRICA
- LATIN AMERICA
Here you can get an updated sample on this report: https://www.credenceresearch.com/sample-request/57840
Company Profiles
6.1 Ariosa Diagnostics, Inc.
6.1.1 Business Description
6.1.2 Financial Health and Budget Allocation
6.1.3 Product Positions/Portfolio
6.1.4 News Coverage
6.2 Berry Genomics Co., Ltd.
6.2.1 Business Description
6.2.2 Financial Health and Budget Allocation
6.2.3 Product Positions/Portfolio
6.2.4 News Coverage
6.3 BGI Diagnostics
6.3.1 Business Description
6.3.2 Financial Health and Budget Allocation
6.3.3 Product Positions/Portfolio
6.3.4 News Coverage
6.4 Illumina, Inc.
6.4.1 Business Description
6.4.2 Financial Health and Budget Allocation
6.4.3 Product Positions/Portfolio
6.4.4 News Coverage
6.5 Laboratory Corporation of America Holdings (LabCorp)
6.5.1 Business Description
6.5.2 Financial Health and Budget Allocation
6.5.3 Product Positions/Portfolio
6.5.4 News Coverage
6.6 LifeCodexx AG
6.6.1 Business Description
6.6.2 Financial Health and Budget Allocation
6.6.3 Product Positions/Portfolio
6.6.4 News Coverage
6.7 Natera, Inc.
6.7.1 Business Description
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Who we are
Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.
Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.
Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Web: https://www.credenceresearch.com
LinkedIn @ https://us.linkedin.com/company/credenceresearch
